Newstral
Article
post-gazette.com on 2015-04-27 16:04
Mylan rejects Teva Pharmaceutical's takeover bid
Related news
- Mylan rejects Teva’s $40 billion takeover bidtriblive.com
- Perrigo survives Mylan takeover bidDetroit Free Press
- Foundation triggers Mylan takeover defense seen as a roadblock for Teva bidtriblive.com
- Teva ends hostile bid for Mylanbizjournals.com
- Teva fires back at Mylan, defending bid, attacking Mylan bossHaaretz
- Drugmaker Perrigo rejects Mylan takeover bidpost-gazette.com
- Mylan foundation to block Teva pharma’s hostile takeover bidtimesofisrael.com
- Teva abandons Mylan takeover bid in favor of Allergan dealobserver-reporter.com
- Teva makes $40.1-billion unsolicited takeover bid for MylanThe Globe and Mail
- Report: Perrigo shareholders reject Mylan takeover bidpost-gazette.com
- Teva accuses Mylan of ‘desperate attempt’ to suppress bidtriblive.com
- Mylan formally launches takeover bid for Perrigopost-gazette.com
- FTeva set to lift Mylan bid to up to $43bnft.com
- Mylan skeptical of rumored Teva bid; hasn’t received offerobserver-reporter.com
- The Ticker / Perrigo board unanimously rejects Mylan takeover bidHaaretz
- Mylan to drop 7 products to win antitrust approval in Perrigo takeover bidtriblive.com
- Perrigo rejects Mylan's takeover bidbizjournals.com
- Mylan Rejects $40 Billion Teva Takeover Offer, Calls Stock 'Low-Quality'Forbes
- Mylan chief: Acquisition by Teva not feasibleHaaretz
- Teva offers to buy Mylan for $40.1Bobserver-reporter.com